Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Havn Life Sciences Inc
(OP:
HAVLF
)
0.0001
UNCHANGED
Last Price
Updated: 1:06 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.0001
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0001
Today's Range
0.0001 - 0.0001
52wk Range
0.0001 - 0.1500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy.
Via
Benzinga
HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
August 19, 2022
Biotech psychedelics company HAVN Life Sciences Inc. (OTC: HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean (“ABO”), previously announced on July...
Via
Benzinga
Performance
YTD
-99.83%
-99.83%
1 Month
N/A
N/A
3 Month
-99.08%
-99.08%
6 Month
-99.74%
-99.74%
1 Year
-99.46%
-99.46%
More News
Read More
Learn About HAVN Life's New Shares Consolidation, What Changes And What Remains
August 01, 2022
Via
Benzinga
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
June 28, 2022
Via
Benzinga
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
April 30, 2022
From
HAVN Life Sciences Inc.
Via
AccessWire
HAVN Life Sciences (CSE: HAVN) (OTC: HAVLF) Featured in Coverage of Planet MicroCap’s Virtual Investor Conference
April 14, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
HAVN Life Sciences (HAVLF) Featured in Coverage of Investor Summit Group’s Q1 Virtual Event
March 07, 2022
Via
Investor Brand Network
Topics
Economy
Exposures
Supply Chain
Psyched: Cathie Wood Invests In Psychedelics Co ATAI, Bill Approved in Utah, AI Startup To 'Design States Of Mind'
February 14, 2022
Via
Benzinga
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
February 10, 2022
Via
Benzinga
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
December 20, 2021
Via
Benzinga
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
November 23, 2021
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
Via
Benzinga
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
From
Stock News Now
Via
AccessWire
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Via
Benzinga
Former Tilray CEO Joins Psychedelics Company
October 07, 2021
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) Featured in Virtual Coverage of LD Micro’s Main Event
October 01, 2021
Via
Investor Brand Network
Psyched: Delic Buys 10 Ketamine Clinics For $10M, Atai Launches Ibogaine Human Trials, Small Pharma Concludes Phase 1 DMT Study
September 27, 2021
Via
Benzinga
HAVN Life Announces Supply and Distribution MOU with Mycrodose Therapeutics
September 23, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Exposures
Product Safety
HAVN Life Announces Distribution Deal with Horizon Grocery + Wellness
September 21, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Supply Chain
Exposures
Supply Chain
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
September 13, 2021
Via
Benzinga
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Via
Benzinga
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
August 25, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
HAVN Life Harvests First Crop of Psilocybin Mushrooms at its Jamaica Facility
August 03, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Psyched: Field Trip Uplists To Nasdaq, MindMed To Study DMT, Atai Launches New Subsidiary, AOC's Psychedelics Amendment Rejected
August 02, 2021
Via
Benzinga
HAVN Life Natural Health Products Now Available on Amazon.ca
July 29, 2021
From
Havn Life Sciences Inc.
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.